معرفی
Dr. Paul M. Barr is a Professor of Medicine in the Department of Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He serves as the Director of the Clinical Trials Office for the Wilmot Cancer Institute and is a Medical Director for the Cancer Center Clinical Trials Office. Dr. Barr is affiliated with the University of Rochester Medical Faculty Group and Accountable Health Partners, providing care at the Wilmot Cancer Center and Strong Memorial Hospital in Rochester, NY.
Dr. Barr received his medical degree from Northeast Ohio Medical University in 2000. He completed his internship, residency and chief residency in Internal Medicine at University Hospitals Cleveland Medical Center (2000-2004), followed by a fellowship in Hematology & Oncology at the same institution (2004-2007).
Dr. Barr's research focuses on the development of novel therapeutics for patients with chronic lymphocytic leukemia (CLL) and lymphoma. His work has centered on targeted therapies, particularly BTK inhibitors like ibrutinib, and combination approaches including venetoclax. He has led numerous clinical trials investigating new treatment strategies for CLL, small lymphocytic lymphoma (SLL), and various forms of non-Hodgkin lymphoma. His research has significantly contributed to understanding long-term outcomes, treatment sequencing, and mechanisms of resistance in hematologic malignancies.
Analysis of Dr. Barr's recent publications reveals a strong emphasis on optimizing treatment approaches for CLL/SLL, with particular focus on BTK inhibitors, venetoclax-based regimens, and treatment sequencing strategies. His work spans both clinical trials and real-world evidence studies, addressing critical questions about long-term efficacy, safety, and optimal management strategies for patients with hematologic malignancies.
- Lymphoma Research Foundation Clinical Investigator (2012-2015)
- NIH Loan Repayment Program Award Recipient (2011-2015)
- Wilmot Cancer Research Fellowship (2011-2014)
- American Society of Hematology Clinical Research Training Institute (2009)
- NIH/NCI K12 Paul Calabresi Scholar (2008)
- John W. Harris, MD Hematology Scholar Award (2006-2007)
As Director of the Clinical Trials Office for the Wilmot Cancer Institute, Dr. Barr oversees numerous clinical trials while educating patients about their disease and treatment options. He is actively involved in multiple national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma, serving as principal investigator on several local and national studies. Dr. Barr is a member of the lymphoma committee in the Southwest Oncology Group and has received significant research funding including NIH awards for his work on novel therapeutic approaches.
Dr. Barr works within the Wilmot Cancer Institute's Hematology/Oncology team, collaborating with specialists in lymphoma and leukemia treatment. His clinical focus includes non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia, with particular expertise in developing and implementing clinical trials for these conditions.
